MSH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.54494211762812E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.03920025099569E-10 |
Normal-vs-Stage2 |
1.95041999999646E-05 |
Normal-vs-Stage3 |
1.49540380078861E-11 |
Normal-vs-Stage4 |
1.63158375698913E-12 |
Stage1-vs-Stage2 |
8.555400E-01 |
Stage1-vs-Stage3 |
8.537600E-02 |
Stage1-vs-Stage4 |
2.437900E-03 |
Stage2-vs-Stage3 |
3.467000E-01 |
Stage2-vs-Stage4 |
6.401800E-02 |
Stage3-vs-Stage4 |
1.758400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.84097181943343E-12 |
Normal-vs-AfricanAmerican |
1.64634972321664E-12 |
Normal-vs-Asian |
2.119800E-03 |
Caucasian-vs-AfricanAmerican |
2.379000E-03 |
Caucasian-vs-Asian |
7.590800E-01 |
AfricanAmerican-vs-Asian |
4.057600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.54951656745106E-15 |
Normal-vs-Female |
1.27779997693978E-09 |
Male-vs-Female |
8.559700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.59340000042086E-07 |
Normal-vs-Age(41-60Yrs) |
2.54219978401693E-11 |
Normal-vs-Age(61-80Yrs) |
1.45660150607796E-11 |
Normal-vs-Age(81-100Yrs) |
1.54299999999274E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.832400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.220400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.795000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.794600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.282000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.674600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.680400E-03 |
Normal-vs-Grade 2 |
2.06369999977696E-08 |
Normal-vs-Grade 3 |
1.72595271408227E-12 |
Normal-vs-Grade 4 |
1.6242562850266E-12 |
Grade 1-vs-Grade 2 |
8.091400E-01 |
Grade 1-vs-Grade 3 |
8.299600E-02 |
Grade 1-vs-Grade 4 |
4.915700E-03 |
Grade 2-vs-Grade 3 |
6.802700E-03 |
Grade 2-vs-Grade 4 |
2.22739999999888E-07 |
Grade 3-vs-Grade 4 |
3.777800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.55333999999341E-05 |
Normal-vs-ccB subtype |
1.62792002100787E-12 |
ccA subtype-vs-ccB subtype |
1.53089999999079E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.03580033439243E-10 |
Normal-vs-N1 |
1.57878E-05 |
N0-vs-N1 |
2.796600E-01 |
|
|